Click here to read a message to our valuable clients regarding our response to COVID-19

Pfizer delays major M&A as it awaits U.S. tax reform clarity

Pfizer delays major M&A as it awaits U.S. tax reform clarity – Thomson Reuters Tax & Accounting http://tmsnrt.rs/2uZWegE

This entry was posted on Thursday, August 3rd, 2017 at 1:24 pm. Both comments and pings are currently closed.